TMO vs VRT: Which Is the Better Buy?
Side-by-side comparison of Thermo Fisher Scientific Inc. and Vertiv Holdings Co — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
VS
Vertiv Holdings Co · Industrials
$305.14
-19.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+10.1%).
TMO trades at a lower forward P/E
(25.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
TMO |
VRT |
| Current Price |
$462.60 |
$305.14 |
| Fair Value Estimate |
$509.20 |
$246.77 |
| Upside to Fair Value |
+10.1%
|
-19.1%
|
| Market Cap |
$171.9B |
$116.8B |
| Forward P/E |
25.1x
|
75.0x
|
| EV / EBITDA |
19.0x
|
50.1x
|
| Price / Sales |
3.8x
|
10.8x
|
| Price / FCF |
25.5x
|
50.5x
|
| Revenue Growth YoY |
+6.2%
|
+30.1%
|
| Gross Margin |
39.4%
|
36.2%
|
| Operating Margin |
17.8%
|
18.5%
|
| Return on Equity |
13.3%
|
42.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.92%
|
1.98%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Vertiv Holdings Co operates in the electrical equipment and parts industry within the industrials sector, focusing on critical digital infrastructure technology products and services. The company has demonstrated strong business quality with a 42.1% return on equity, 30.1% revenue growth, and 137.1% earnings growth in the most recent quarter, supported by solid margins including a 36.2% gross mar…
Accumulation Zones
| Metric |
TMO |
VRT |
| Zone Low |
$381.90 |
$185.08 |
| Zone High |
$432.82 |
$209.75 |
| In Buy Zone? |
No
|
No
|